Proximity Work in Family Medicine Groups : the Impact of Pharmacists
Not Applicable
Completed
- Conditions
- Health Services
- Interventions
- Other: Pharmacist clinical intervention
- Registration Number
- NCT02963636
- Lead Sponsor
- Laval University
- Brief Summary
The project objective is to evaluate the impact of the recent addition of pharmacists within family medicine groups (FMGs) on organizational and clinical parameters. The process by which changes occur and the level of pharmacists' activities will also be assessed. The ultimate goal of the project is the development of an accompanying guide to facilitate the work of the pharmacist in monitoring complex patients in primary care medical clinics.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
- Willing to meet with the pharmacist and;
- Consuming drugs of four or more different pharmacological classes or having to take at least four doses per day and;
- aged 70 or over with at least two criteria of vulnerability or aged less than 70 with at least 3 criteria of vulnerability or had a recent loss of autonomy or in post- hospitalization with medication changes in the hospital.
Exclusion Criteria
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Pharmacist clinical intervention Pharmacist clinical intervention Patients exposed to the pharmacist intervention
- Primary Outcome Measures
Name Time Method Number of drug related problems 3 to 6 months
- Secondary Outcome Measures
Name Time Method Regimen complexity 3 to 6 months Medication regimen complexity index (MRCI)
Medication adherence 3 to 6 months Proportion of days covered (PDC)
Quality of care provided by the clinical team (pharmacists, doctors, nurses, etc.) 3 to 6 months Quality indicators (proposed by INESSS)
Trial Locations
- Locations (1)
CIUSSS de la Capitale-Nationale
🇨🇦Québec, Quebec, Canada